Breathing new life into disease diagnosis

PulmoBioMed’s PBM-HALE™ New research shows 100 per cent effectiveness of an innovative breath sampling device developed by Northumbria University medtech spinout, PulmoBioMed. PBM-HALE™ is a game-changing device that could revolutionise diagnosis of a range of diseases, including COVID-19. The hand-held aerosol collecting device allows sampling of the lung in a non-invasive way – by patients […]
In the press: North East Times speaks to three promising spin-outs

North East Times magazine’s September issue shines a light on three of Northern Accelerator’s latest spin-out companies from Newcastle and Durham Universities. Skin Life Analytics, ESP Diagnostics and Respiratone were supported by Northern Accelerator to spin-out of the region’s universities recently, utilising our Executives into Business programme and other support to ensure the best chance […]
Northern Accelerator funding backs project to recycle CO2
Carbon dioxide and water could be recycled into renewable future fuels under a system developed by experts at Northumbria University. A £50,000 award from Northern Accelerator’s pre-incorporation funding will further a collaboration between Northumbria University and SUEZ recycling and recovery. The project aims to create a safe and sustainable pipeline of carbon-based fuels made from […]
Develop the real-world impact of your research

Northern Accelerator is pleased to offer a limited number of places on the next cohort of its prestigious training course, Innovators. Innovators gives researchers at partner universities the chance to develop the skills to make a real-world impact with their research. As part of a small multidisciplinary cohort, you’ll take part in a series of […]
AMLo Biosciences raises £2.45m to further develop early stage skin cancer test

AMLo Biosciences Ltd (AMLo), an innovative medical device company spun out of Newcastle University specialising in the early detection of skin cancers, has secured significant further investment totalling £2.45m. At present all early stage melanomas are treated in a similar way, sometimes involving invasive surveillance diagnostics designed to identify the few high-risk melanomas at the […]
In the press: North East Times features inspiring spin-out journey

In April’s North East Times magazine, Editor Steven Hugill caught up with Billy Webber, CEO of XR Therapeutics. Billy leads the Newcastle University spin-out, having been brought on board as CEO through Northern Accelerator’s Executives into Business programme. Read the full feature to find out more about how XR Therapeutics is bringing its next generation […]
Visit us at VentureFest North East

We’re attending VentureFest North East on Wednesday 30 March 2022, alongside our partner universities and Orbit , Durham University’s Enterprise Zone. Come and talk to us about Executives into Business and how you can get involved with supporting or driving a spin-out business from our region’s universities. And hear about the full range of support we […]
Sphera announces close of £1.9 million funding round

Sphera, a Durham University spin-out helping the construction sector build a net-zero world, has announced the close of a £1.9 million funding round. By recycling what most deem unrecyclable, Sphera has created a carbon negative aggregate for concrete. Their building materials are tackling the colossal carbon footprint of traditional concrete, which makes up 8% of […]
Newcastle biotech spin-out raises £1.75m to accelerate technology launch

Biotech technology disrupter CellulaREvolution, which aims to revolutionise the way cells are grown, has raised £1.75 million from a group of notable investors in a round led by Happiness Capital, including Allusion One, the first investment arm of Allusion. The investment will be used to accelerate research & development and strengthen their commercial team as […]
Northern Accelerator’s first spin-out secures further £425k investment

Atelerix was spun out of Newcastle University in 2017 by three co-founders, Professor Che Connon, Dr Steve Swioklo and Dr Mick McLean. The conventional freezing and thawing of cells and tissues through cryogenics can be hugely damaging, and these cells often die or change their function in the process. To tackle this problem, Atelerix has […]